Bringing prostate cancer germline genetics into clinical practice

S Das, SS Salami, DE Spratt, SD Kaffenberger… - Journal of …, 2019 - journals.lww.com
Purpose: Until recently the role of germline genetics in prostate cancer care was not well
defined. While important questions remain, we reviewed the current understanding of …

[HTML][HTML] Understanding the uptake and challenges of genetic testing guidelines for prostate cancer patients

Y Suri, JP Yasmeh, A Basu - Cancer Treatment and Research …, 2022 - Elsevier
Background Multiple studies have confirmed a high prevalence of prognostic germline
mutations in prostate cancer. In recognition, the NCCN guidelines and recommendations for …

[HTML][HTML] Prostate cancer in Southern Africa: does Africa hold untapped potential to add value to the current understanding of a common disease?

VM Hayes, MSR Bornman - Journal of Global Oncology, 2018 - ncbi.nlm.nih.gov
Prostate cancer (PCa) is the most common cancer diagnosis in men from economically
stable countries and is a leading cause of cancer-related death. 1 However, the population …

Gene-based confirmatory germline testing following tumor-only sequencing of prostate cancer

H Truong, K Breen, S Nandakumar, DD Sjoberg… - European Urology, 2023 - Elsevier
Background Tumor-only genomic profiling is an important tool in therapeutic management of
men with prostate cancer. Since clinically actionable germline variants may be reflected in …

A pilot study of clinical targeted next generation sequencing for prostate cancer: consequences for treatment and genetic counseling

HH Cheng, N Klemfuss, B Montgomery… - The …, 2016 - Wiley Online Library
BACKGROUND Targeted next generation sequencing (tNGS) is increasingly used in
oncology for therapeutic decision‐making, but is not yet widely used for prostate cancer. The …

Genomic profiling of prostate cancers from men with African and European ancestry

Y Koga, H Song, ZR Chalmers, J Newberg, E Kim… - Clinical Cancer …, 2020 - AACR
Abstract Purpose: African American (AFR) men have the highest mortality rate from prostate
cancer (PCa) compared with men of other racial/ancestral groups. Differences in the …

Observed evidence for guideline‐recommended genes in predicting prostate cancer risk from a large population‐based cohort

J Wei, W Yang, Z Shi, L Lu, Q Wang… - The …, 2021 - Wiley Online Library
Background Germline testing for prostate cancer (PCa) is now recommended by the
National Comprehensive Cancer Network. While multi‐gene testing has been proposed …

Addition of germline testing to tumor-only sequencing improves detection of pathogenic germline variants in men with advanced prostate cancer

JE Berchuck, D Boiarsky, R Silver, R Sunkara… - JCO Precision …, 2022 - ascopubs.org
PURPOSE Guidelines recommend somatic and germline testing for men with advanced
prostate cancer (PCa). Barriers to widespread implementation result in underutilization of …

Inherited mutations in Chinese men with prostate cancer

Y Zhu, Y Wei, H Zeng, Y Li, CF Ng, F Zhou… - Journal of the National …, 2022 - jnccn.org
Background: Although China accounts for 7.8% of worldwide new prostate cancer (PCa)
cases and 14.5% of new deaths according to GLOBOCAN 2020, the risk of PCa associated …

Rare germline mutations in African American men diagnosed with early‐onset prostate cancer

JL Beebe‐Dimmer, KA Zuhlke, AM Johnson… - The …, 2018 - Wiley Online Library
Background African Americans have both a higher incidence of prostate cancer and greater
disease‐specific mortality compared with non‐Hispanic whites. Historically, the investigation …